Dabur Research Foundation

Executive Summary

Dabur Research Foundation (DRF) is a preclinical contract research organization headquartered in Ghaziabad, India, with over 20 years of experience. It provides end-to-end services including in-vitro, ex-vivo, and in-vivo models, DMPK, toxicology, and regulatory consulting. DRF supports drug discovery across a broad range of therapeutic areas such as oncology, metabolic disorders, neurology, and traditional medicine. Leveraging its expertise, the company serves both pharmaceutical and biotechnology clients, offering cost-effective solutions for early-stage development. With a team of 200-500 employees, DRF is positioned as a reliable partner in the growing Indian CRO market, which benefits from increasing R&D outsourcing by global pharma companies.

Upcoming Catalysts (preview)

• Q3 2026Receipt of OECD GLP certification for new toxicology facility70% success
• Q4 2026Strategic partnership with a top-10 pharma for metabolic disease programs60% success
• Q2 2027Launch of biologics and biosimilar testing services50% success